Calla Lily Clinical Care Ltd. / Callaly, is an award-winning women’s health company focused on improving care across the female life course. The company develops thoughtful, evidence-based products including Tampliner, Callavid, and Lilyvid, designed to address long-standing gaps in women’s healthcare.
Founded on the belief that women deserve better: better outcomes, better experiences, and higher standards— Calla Lily Clinical Care brings together clinical insight, research, and human-centred design to create solutions that are both effective and respectful of women’s bodies. Callavid is a vaginal delivery platform initially focused on fertility and pregnancy, including support for IVF and the prevention of threatened miscarriage, with the potential to be used more widely. Future applications include treatments for menopause, more targeted approaches to cancer care, and new ways of delivering beneficial therapies that could reduce reliance on antibiotics.
At the heart of the brand is a commitment to dignity, comfort, and choice, alongside a broader mission to challenge historic neglect in women’s healthcare and to help raise expectations of how women’s health products are developed and delivered.
Keywords: organic, health, women, tampon, tampliner, menstrual, callavid, femtech, women’s health, menopause
Sector: Wholesale/Retail
Size: 10-49 employees
B Corp Certified – Impact Score: 103.2
